Trexquant Investment LP Compugen LTD Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $244,324 - $427,716	-59,737 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$5.8 - $8.02 $346,474 - $479,090	59,737 New	59,737 $357,000
Q2 2021 Aug 12, 2021	SELL	$6.87 - $9.16 $91,776 - $122,368	-13,359 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$7.67 - $13.77 $102,463 - $183,953	13,359 New	13,359 $115,000

13.4M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $152M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.